Mepolizumab in CRSwNP/ECRS and NP: the phase III randomised MERIT trial in Japan, China, and Russia Article

sustainable development goals

publication date

  • January 1, 2024

webpage

published in

keywords

  • eosinophils
  • interleukin-5
  • mepolizumab
  • nasal polyps
  • rhinosinusitis

volume

  • 62

issue

  • 5